Residency · Oklahoma City, OK
Sponsored by University of Oklahoma College of Medicine
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 2025 · 868 citations · Usman Baber
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Journal of the American College of Cardiology · 2025 · 451 citations · Usman Baber
Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 2025 · 401 citations · Usman Baber
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
JAMA · 2023 · 730 citations · Fatima Sukhera
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine.
Journal of vascular surgery. Venous and lymphatic disorders · 2024 · 143 citations · Suman Wasan
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Cara Mathews
Palliative Care for Patients With Cancer: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 279 citations · Ryan Nipp
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet (London, England) · 2022 · 698 citations · Sami Ibrahimi